GlassScriptPhysician profile
Sumana G Reddy
NPI 1588741888
$10,335.06
in general payments reported to CMS, 2019-2025
55 companies · $1,896 in 2025
The $1,896 reported for 2025 was more than what 76% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,623 · 2020: $571 · 2021: $540 · 2022: $1,497 · 2023: $2,155 · 2024: $2,053 · 2025: $1,896.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,899 · Education: $205.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,898.96 |
| Education | $205.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $1,297.34 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $1,029.32 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Tandem Diabetes Care, INC. | $948.27 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Xeris Pharmaceuticals, INC. | $591.37 | 2021-2025 | Gvoke Hypopen, Recorlev |
| Corcept Therapeutics | $514.70 | 2019-2025 | Korlym |
| Sanofi-Aventis U.S. LLC | $513.03 | 2019-2025 | |
| Abbott Laboratories | $511.15 | 2021-2025 | Freestyle Libre 3 |
| Amgen INC. | $426.54 | 2019-2025 | Tepezza, Evenity, Repatha |
| Radius Health, INC. | $395.36 | 2019-2025 | Tymlos |
| Insulet Corporation | $344.18 | 2019-2025 | Omnipod |
| Mannkind Corporation | $330.58 | 2019-2025 | Afrezza |
| Bigfoot Biomedical INC | $262.33 | 2022-2023 | Unity Diabetes Management System |
| Astellas Pharma US INC | $235.67 | 2023-2025 | Veozah, Myrbetriq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $222.94 | 2019-2025 | Jardiance, Synjardy |
| Beta Bionics, INC. | $202.10 | 2023-2024 | Ilet Bionic Pancreas |
Show all 55 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sumana Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.